1992 - Fellow of the Royal Society of Edinburgh
His primary areas of investigation include Internal medicine, Cardiology, Surgery, Myocardial infarction and Pravastatin. In his study, Obesity and Body mass index is inextricably linked to Diabetes mellitus, which falls within the broad field of Internal medicine. His research on Cardiology frequently connects to adjacent areas such as Prospective cohort study.
The Surgery study combines topics in areas such as Vitamin and B vitamins. His studies deal with areas such as Placebo and Blood pressure as well as Myocardial infarction. His study on Pravastatin also encompasses disciplines like
The scientist’s investigation covers issues in Internal medicine, Cardiology, Electrocardiography, Myocardial infarction and QRS complex. The study of Internal medicine is intertwined with the study of Surgery in a number of ways. The Heart failure research Peter W. Macfarlane does as part of his general Cardiology study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
His Myocardial infarction study often links to related topics such as Placebo. The various areas that Peter W. Macfarlane examines in his QRS complex study include Genetics and QT interval. His Prospective cohort study research focuses on Hazard ratio and how it relates to Stroke.
Peter W. Macfarlane mostly deals with Internal medicine, Cardiology, Atrial fibrillation, QRS complex and Genome-wide association study. His is doing research in Myocardial infarction, Disease, Prospective cohort study, Subclinical infection and Hazard ratio, both of which are found in Internal medicine. As a part of the same scientific study, Peter W. Macfarlane usually deals with the Myocardial infarction, concentrating on Placebo and frequently concerns with Anesthesia, Percutaneous coronary intervention and Randomized controlled trial.
Peter W. Macfarlane studies Cardiology, namely Electrocardiography. His Atrial fibrillation research includes themes of Stroke, Single lead, Risk of mortality and Heart failure. As a member of one scientific family, he mostly works in the field of QRS complex, focusing on QT interval and, on occasion, Pharmacogenomics and Epidemiology.
His primary scientific interests are in Internal medicine, Cardiology, Genetics, Genome-wide association study and QRS complex. His Biomedical sciences research extends to Internal medicine, which is thematically connected. His Cardiology research is mostly focused on the topic Electrocardiography.
His Genome-wide association study study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
J Shepherd;S M Cobbe;I Ford;C G Isles.
The New England Journal of Medicine (1995)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen.
The Lancet (2002)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh.
The Lancet (2010)
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Naveed Sattar;Allan Gaw;Olga Scherbakova;Ian Ford.
West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials
J Shepherd;SM Cobbe;AR Lorimer;JH McKillop.
The Lancet (1996)
Pravastatin and the Development of Diabetes Mellitus Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study
Dilys J. Freeman;John Norrie;Naveed Sattar;R. Dermot G. Neely.
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch;Angus MacCuish;Iain Campbell;Stuart Cobbe.
Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I: The Electrocardiogram and Its Technology A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology
Paul Kligfield;Leonard S. Gettes;James J. Bailey;Rory Childers.
Journal of the American College of Cardiology (2007)
Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
CJ Packard;J Shepherd;SM Cobbe;Jane B Ford.
Practice Standards for Electrocardiographic Monitoring in Hospital Settings An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young
Barbara J. Drew;Robert M. Califf;Marjorie Funk;Elizabeth S. Kaufman.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: